Barr to market generic Nordette oral contraceptive as Portia
POMONA, N.Y. -- Barr Laboratories announced that the FDA has approved its application to manufacture and market a generic version of Wyeth Laboratories' Nordette Tablets oral contraceptive 28-day regimen.
The Company plans to market the product as a branded generic using the Portia trademark.
Nordette is a regimen of oral contraceptives that contains 0.15 mg of levonorgestrel and 0.03 mg of ethinyl estradiol, and is indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception. The product is supplied in 21-day and 28-day regimens.
Posted: June 2002